AU2014227598B2 - Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof - Google Patents

Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof Download PDF

Info

Publication number
AU2014227598B2
AU2014227598B2 AU2014227598A AU2014227598A AU2014227598B2 AU 2014227598 B2 AU2014227598 B2 AU 2014227598B2 AU 2014227598 A AU2014227598 A AU 2014227598A AU 2014227598 A AU2014227598 A AU 2014227598A AU 2014227598 B2 AU2014227598 B2 AU 2014227598B2
Authority
AU
Australia
Prior art keywords
composition
sodium sulfate
oral pharmaceutical
less
pharmaceutical tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2014227598A
Other languages
English (en)
Other versions
AU2014227598A1 (en
Inventor
Edmund V. Dennett Jr.
David S. Wells
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Braintree Laboratories Inc
Original Assignee
Braintree Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braintree Laboratories Inc filed Critical Braintree Laboratories Inc
Publication of AU2014227598A1 publication Critical patent/AU2014227598A1/en
Application granted granted Critical
Publication of AU2014227598B2 publication Critical patent/AU2014227598B2/en
Priority to AU2019201511A priority Critical patent/AU2019201511A1/en
Priority to AU2020213378A priority patent/AU2020213378A1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D5/00—Sulfates or sulfites of sodium, potassium or alkali metals in general
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2014227598A 2013-03-15 2014-03-14 Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof Ceased AU2014227598B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2019201511A AU2019201511A1 (en) 2013-03-15 2019-03-05 Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
AU2020213378A AU2020213378A1 (en) 2013-03-15 2020-08-07 Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798759P 2013-03-15 2013-03-15
US61/798,759 2013-03-15
PCT/US2014/028805 WO2014144407A1 (en) 2013-03-15 2014-03-14 Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019201511A Division AU2019201511A1 (en) 2013-03-15 2019-03-05 Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof

Publications (2)

Publication Number Publication Date
AU2014227598A1 AU2014227598A1 (en) 2015-08-27
AU2014227598B2 true AU2014227598B2 (en) 2018-12-06

Family

ID=50680164

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2014227598A Ceased AU2014227598B2 (en) 2013-03-15 2014-03-14 Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
AU2019201511A Abandoned AU2019201511A1 (en) 2013-03-15 2019-03-05 Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
AU2020213378A Abandoned AU2020213378A1 (en) 2013-03-15 2020-08-07 Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2019201511A Abandoned AU2019201511A1 (en) 2013-03-15 2019-03-05 Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
AU2020213378A Abandoned AU2020213378A1 (en) 2013-03-15 2020-08-07 Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof

Country Status (25)

Country Link
US (2) US9919007B2 (enExample)
EP (2) EP3563838A1 (enExample)
JP (2) JP6441890B2 (enExample)
CN (2) CN105142617B (enExample)
AU (3) AU2014227598B2 (enExample)
BR (1) BR112015019776A2 (enExample)
CA (1) CA2903283C (enExample)
CY (1) CY1122387T1 (enExample)
DK (1) DK2968174T3 (enExample)
EA (2) EA034234B1 (enExample)
ES (1) ES2764462T3 (enExample)
HK (1) HK1214519A1 (enExample)
HR (1) HRP20192227T1 (enExample)
HU (1) HUE046754T2 (enExample)
IL (1) IL241367A0 (enExample)
LT (1) LT2968174T (enExample)
ME (1) ME03656B (enExample)
MX (1) MX377525B (enExample)
PE (1) PE20151543A1 (enExample)
PL (1) PL2968174T3 (enExample)
PT (1) PT2968174T (enExample)
RS (1) RS59667B1 (enExample)
SI (1) SI2968174T1 (enExample)
SM (1) SMT201900716T1 (enExample)
WO (1) WO2014144407A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA034234B1 (ru) 2013-03-15 2020-01-20 Брейнтри Лабораторис, Инк. Пероральные фармацевтические таблетированные композиции двойного применения, содержащие сульфат натрия или его комбинацию с другими сульфатными солями, и способы их получения и применения
EP3191105A4 (en) * 2014-09-12 2018-05-02 Braintree Laboratories, Inc. Sulfate salt solution laxative compositions and methods of use thereof
US11007170B2 (en) 2017-02-02 2021-05-18 Panaxia Pharmaceutical Industries Ltd. Composition for buccal or sublingual administration of cannabis extract and methods for making same
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
MX2023004685A (es) * 2020-10-26 2023-06-22 Braintree Laboratories Inc Formulaciones de sales de sulfato para la limpieza del colon.
CN116509809B (zh) * 2023-04-19 2024-12-03 山东齐都药业有限公司 复方硫酸钠片剂及其制备方法与应用
US12239659B2 (en) 2023-06-15 2025-03-04 Braintree Laboratories, Inc. Methods of administering safe colon cleansing compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005102364A1 (en) * 2004-04-23 2005-11-03 Norgine Europe Bv Compressed pharmaceutical compositions comprising peg and electrolytes
WO2012013928A1 (en) * 2010-07-27 2012-02-02 Norgine Bv Compositions

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873694A (en) 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
JPS5438167B2 (enExample) 1974-04-27 1979-11-19
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2058565B (en) 1979-09-21 1983-12-07 Leo Pharm Prod Ltd Layer tablets
NZ198241A (en) 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE3134591A1 (de) 1981-09-01 1983-03-10 Bayer Ag, 5090 Leverkusen Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren
JPS5839618A (ja) 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
EP0080862B1 (en) 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS59101423A (ja) 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
JPS6097919A (ja) 1983-11-01 1985-05-31 Furointo Sangyo Kk 圧縮成形用賦形剤の製造方法
NL8400911A (nl) 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
AU6196786A (en) 1985-08-01 1987-03-05 Braintree Laboratories Inc. Low-sodium laxative and lavage formulation
US4753801A (en) 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
ES2061623T3 (es) 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
IL86859A (en) 1987-07-10 1991-12-15 E Z Em Inc Aqueous cathartic solution containing inorganic salts
NO168563C (no) 1987-09-28 1992-03-11 Collett Marwell Hauge As Anvendelse av en organoleptisk akseptabel blanding av magnesiumsalter som mineraladditiv
JPH0194937A (ja) * 1987-10-06 1989-04-13 Yokohama Yushi Kogyo Kk 微粉状ミネラル類の被覆物の製造方法
US4837030A (en) 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US5211958A (en) 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
US5274001A (en) 1987-12-24 1993-12-28 Borody Thomas J Orthostatic lavage solutions
WO1989009604A1 (en) 1988-04-05 1989-10-19 Dale Driver Dietary mineral sulfur supplement
JPH0816061B2 (ja) 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
IT1229568B (it) 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
WO1993017588A1 (en) 1992-03-11 1993-09-16 The Procter & Gamble Company Psyllium drink mix compositions containing granulated base
JPH08505609A (ja) 1992-11-24 1996-06-18 ブロック・ドラッグ・カンパニー・インク 胃腸洗浄用薬剤組成物
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5498425A (en) 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
AUPN634595A0 (en) 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
ATE235894T1 (de) 1996-05-08 2003-04-15 Craig A Aronchick Nichtwässrige abführmittel für den kolon
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
AU745361B2 (en) 1997-04-18 2002-03-21 Janssen Pharmaceutica N.V. Use of 5HT3 antagonists for promoting intestinal lavage
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
CA2348024C (en) 1998-10-30 2008-02-19 Mcneil-Ppc, Inc. Granular, free-flowing pharmaceutical composition, and straw-like dosage form for oral administration thereof
US6645481B1 (en) 2000-09-28 2003-11-11 Braintree Laboratories, Inc. Method of achieving overnight laxation and control of bowel function
US6887492B2 (en) 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
AUPR590701A0 (en) 2001-06-25 2001-07-19 Colocaps Pty Ltd Laxative preparation
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US20040071779A1 (en) 2002-10-09 2004-04-15 Keiser Dale Arthur Gelled laxative compositions
US7291324B2 (en) 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
GB0224909D0 (en) 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
WO2005007170A1 (en) 2003-07-09 2005-01-27 Braintree Laboratories, Inc. Method for treating irritable bowel syndrome using laxatives
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
SI1750702T1 (sl) 2004-06-04 2011-03-31 Braintree Lab Postopek za äśiĺ äśenje äśrevesja
WO2007013093A2 (en) 2005-04-01 2007-02-01 Shiv Prakash Laxative formulation containing a triphala extract
WO2006118562A1 (en) 2005-04-29 2006-11-09 Inkine Pharmaceutical Company, Inc. Purgative composition and uses thereof
AU2006244112B2 (en) 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US20070087056A1 (en) 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
US20070082061A1 (en) 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
EP1976520B1 (en) 2005-12-29 2011-04-27 Braintree Laboratories, Inc. Kit comprising an osmotic laxative and a stimulant laxative for preparing the colon for virtual colonoscopy
US8067033B2 (en) * 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
US7998510B2 (en) 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
WO2008141368A1 (en) 2007-05-17 2008-11-27 David Lubowski Combination laxative compositions comprising a colonic stimulant and a bulking laxative
CA2703002A1 (en) 2007-10-17 2009-04-23 Thomas Jefferson University Bowel purgative and uses thereof
EP2234482B1 (en) 2008-01-16 2015-08-05 Braintree Laboratories, Inc. Sulfate salt prophylaxis and therapies
US20090258090A1 (en) 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
HRP20140939T1 (hr) 2008-05-07 2014-11-21 Salix Pharmaceuticals, Ltd. Davanje preparata za äśišä†enje crijeva i antibiotika za lijeäśenje bolesti crijeva
US20100255122A1 (en) 2009-04-02 2010-10-07 Garren Mary L Edible gelatin bowel preparation and bowel cleansing method
WO2010123901A1 (en) 2009-04-21 2010-10-28 Bachwich Dale R Colon lavage system
US20100285164A1 (en) * 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
GB0912487D0 (en) 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
US20130121916A1 (en) 2010-03-10 2013-05-16 Sergio Baroni Compositions for Colon Lavage and Methods of Making and Using Same
CA2795977A1 (en) 2010-03-12 2011-09-15 Scott Cordray Method of treatment
JP5665372B2 (ja) * 2010-06-02 2015-02-04 旭化成ケミカルズ株式会社 速崩壊性固形製剤
EA024566B1 (ru) 2010-11-04 2016-09-30 Норджин Бв Твердая композиция для приема внутрь (варианты), способ терапевтической или нетерапевтической профилактики желудочно-кишечных расстройств или поддержания здорового состояния желудочно-кишечного тракта с ее помощью (варианты) и упаковка, ее содержащая
BR112013014827A2 (pt) 2010-12-13 2016-10-04 Antony Wettstein formulações gástricas e colônicas e métodos para produzir e usar as mesmas
WO2012091049A1 (ja) * 2010-12-28 2012-07-05 大鵬薬品工業株式会社 口腔内崩壊錠剤
CN103391790B (zh) 2011-01-28 2016-06-15 布伦特里实验室有限公司 用于肠道清洁的方法、组合物以及包装
MX360450B (es) 2011-01-31 2018-11-01 Norgine Bv Mejoras de y relacionadas con composiciones.
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
PT2696690T (pt) 2011-04-15 2017-12-22 Braintree Laboratories Inc Sais de sulfato como potenciador de tempo de trânsito
US8778907B2 (en) 2011-04-27 2014-07-15 Cumberland Pharmaceuticals Lactulose for bowel evacuation
US20140235730A1 (en) 2011-09-23 2014-08-21 Gavis Pharmaceuticals, Llc Solid, edible, chewable laxative composition
JP6240610B2 (ja) 2011-10-27 2017-11-29 サリックス ファーマシューティカルズ，インコーポレイテッド 電解質下剤
US9149493B2 (en) 2011-11-28 2015-10-06 Alfa Wassermann Spa Compositions for bowel cleansing and use thereof
BR112015004165A2 (pt) 2012-08-29 2017-07-04 Salix Pharmaceuticals Inc métodos e composições laxantes para o tratamento de constipação e condições e doenças gastrointestinais relacionadas
BR112015005270B1 (pt) 2012-09-11 2022-11-01 Norgine Bv Composição para mistura com água, solução de limpeza de cólon, seus usos e seu kit
US20140087007A1 (en) 2012-09-27 2014-03-27 Braintree Laboratories, Inc. Bowel cleansing preparations
EA034234B1 (ru) 2013-03-15 2020-01-20 Брейнтри Лабораторис, Инк. Пероральные фармацевтические таблетированные композиции двойного применения, содержащие сульфат натрия или его комбинацию с другими сульфатными солями, и способы их получения и применения

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005102364A1 (en) * 2004-04-23 2005-11-03 Norgine Europe Bv Compressed pharmaceutical compositions comprising peg and electrolytes
WO2012013928A1 (en) * 2010-07-27 2012-02-02 Norgine Bv Compositions

Also Published As

Publication number Publication date
HK1214519A1 (zh) 2016-07-29
PL2968174T3 (pl) 2020-05-18
PE20151543A1 (es) 2015-11-29
AU2019201511A1 (en) 2019-03-28
DK2968174T3 (da) 2019-12-16
IL241367A0 (en) 2015-11-30
WO2014144407A1 (en) 2014-09-18
ME03656B (me) 2020-07-20
EA201992382A2 (ru) 2020-02-28
EP2968174A1 (en) 2016-01-20
US9919007B2 (en) 2018-03-20
US20180207200A1 (en) 2018-07-26
EA034234B1 (ru) 2020-01-20
CN108904462A (zh) 2018-11-30
PT2968174T (pt) 2020-01-15
WO2014144407A8 (en) 2014-11-20
EA201992382A3 (ru) 2020-05-31
CN105142617A (zh) 2015-12-09
RS59667B1 (sr) 2020-01-31
JP6441890B2 (ja) 2018-12-19
HRP20192227T1 (hr) 2020-02-21
CY1122387T1 (el) 2020-11-25
HUE046754T2 (hu) 2020-03-30
MX2015012109A (es) 2016-04-15
CN105142617B (zh) 2018-08-03
CA2903283C (en) 2023-09-05
EP2968174B1 (en) 2019-10-16
MX377525B (es) 2025-03-10
AU2014227598A1 (en) 2015-08-27
EP3563838A1 (en) 2019-11-06
EA201591568A1 (ru) 2015-12-30
SI2968174T1 (sl) 2020-02-28
SMT201900716T1 (it) 2020-01-14
JP2016514677A (ja) 2016-05-23
LT2968174T (lt) 2020-01-10
BR112015019776A2 (pt) 2017-07-18
JP6724114B2 (ja) 2020-07-15
US20160030473A1 (en) 2016-02-04
JP2019023244A (ja) 2019-02-14
CA2903283A1 (en) 2014-09-18
ES2764462T3 (es) 2020-06-03
AU2020213378A1 (en) 2020-08-27

Similar Documents

Publication Publication Date Title
JP6724114B2 (ja) 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法
US20220133778A1 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2007522217A (ja) プロトンポンプ阻害剤、緩衝剤および非ステロイド系抗炎症薬の組み合わせ
TW200938210A (en) Pharmaceutical compositions
CA2609627C (en) Pharmaceutical formulations useful for inhibiting acid secretion
JP4276545B2 (ja) 改良組成物
JP2008500365A (ja) 酸分泌を阻害するために有用な薬学的製剤ならびにその製造方法および使用方法
JPWO2003075919A1 (ja) 塩酸ピルジカイニド含有錠剤（乾式）
CA2175225C (en) Gelatin capsule fill able to foam
PT836472E (pt) Composicoes terapeuticas efervescentes
AU2005331781C1 (en) Pharmaceutical formulations useful for inhibiting acid secretion
AU2011265561B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2025120308A1 (en) An orally disintegrating tablet of paroxetine and its process of preparation
WO2003075918A1 (fr) Comprime contenant du chlorhydrate de pilsicainide (voie humide)
TW202535384A (zh) 雷貝拉唑藥物組合物、其製備方法及用途
JP2007015982A (ja) 緩下剤
JP2007015966A (ja) 口腔内崩壊錠
TW201422224A (zh) 含有達泊西汀游離鹼的口腔用組成物

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired